Who
Andrew E. Singer
Director
Company insider
Files Form 4 as: Director, Kyntra Bio; EVP & CFO, Epizyme.
In numbers
- Trades disclosed
- 106
- Buys
- 0
- Sells
- 17
- Bought
- $0
- Sold
- $325K
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 9 Feb 2015
- Last trade
- 1 Oct 2026
- Last filed
- 6 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Oct 2026filed 6 Oct 2026 | KYNB Kyntra Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —14,000 at $0.00 | filing |
| 9 Aug 2017filed 10 Aug 2017 | Epizyme | SEC FORM 4 Code M | —1,682 | filing |
| 9 Aug 2017filed 10 Aug 2017 | Epizyme | SEC FORM 4 Code M | —778 | filing |
| 9 Aug 2017filed 10 Aug 2017 | Epizymeoption or derivative | SEC FORM 4 Code M | —1,682 at $0.00 | filing |
| 9 Aug 2017filed 10 Aug 2017 | Epizymeoption or derivative | SEC FORM 4 Code M | —778 at $0.00 | filing |
| 10 Jul 2017filed 12 Jul 2017 | Epizyme | SEC FORM 4 Code M | —1,682 | filing |
| 10 Jul 2017filed 12 Jul 2017 | Epizyme | SEC FORM 4 Code M | —777 | filing |
| 10 Jul 2017filed 12 Jul 2017 | Epizymeoption or derivative | SEC FORM 4 Code M | —1,682 at $0.00 | filing |
| 10 Jul 2017filed 12 Jul 2017 | Epizymeoption or derivative | SEC FORM 4 Code M | —777 at $0.00 | filing |
| 30 Jun 2017filed 5 Jul 2017 | Epizyme | SEC FORM 4 Sold | $47K3,024 at $15.50 | filing |
| 9 Jun 2017filed 12 Jun 2017 | Epizyme | SEC FORM 4 Code M | —1,682 | filing |
| 9 Jun 2017filed 12 Jun 2017 | Epizyme | SEC FORM 4 Code M | —777 | filing |
| 9 Jun 2017filed 12 Jun 2017 | Epizymeoption or derivative | SEC FORM 4 Code M | —1,682 at $0.00 | filing |
| 9 Jun 2017filed 12 Jun 2017 | Epizymeoption or derivative | SEC FORM 4 Code M | —777 at $0.00 | filing |
| 9 May 2017filed 11 May 2017 | Epizyme | SEC FORM 4 Code M | —1,682 | filing |
| 9 May 2017filed 11 May 2017 | Epizyme | SEC FORM 4 Code M | —778 | filing |
| 9 May 2017filed 11 May 2017 | Epizymeoption or derivative | SEC FORM 4 Code M | —1,682 at $0.00 | filing |
| 9 May 2017filed 11 May 2017 | Epizymeoption or derivative | SEC FORM 4 Code M | —778 at $0.00 | filing |
| 10 Apr 2017filed 11 Apr 2017 | Epizyme | SEC FORM 4 Code M | —1,682 | filing |
| 10 Apr 2017filed 11 Apr 2017 | Epizyme | SEC FORM 4 Code M | —777 | filing |
News
Kyntra Bio Appoints Andrew E. Singer, MBA to its Board of Directorsmanilatimes.net · 1 Oct 2026
1 headline in the last 90 days name Andrew E. Singer; no company of theirs resolves to a name we track.
Sectors
Related people
Nobody else traded the same names lately.